Example: barber

(3)政府研究開発投資に係る国際比較 我が国の政 …

42 5 1 EU 3 1 3-10 3-10 2007 EU27 2006 Main Science and Technology Indicators 2008/1 OECD World Economic Outlook Database IMF GDP 3-11 3-11 GDP 2007 EU27 2006 Main Science and Technology Indicators 2008/1 OECD World Economic Outlook Database IMF 020406080100120140160 10 43 3-12 3-12 2006 Main Science and Technology Indicators 2008/1 OECD 44 3-13 3-13

43 各国における産学官の研究開発投資比率を見ると、我が国は韓国と並び、企業等による研 究開発投資が多い。

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Transcription of (3)政府研究開発投資に係る国際比較 我が国の政 …

1 42 5 1 EU 3 1 3-10 3-10 2007 EU27 2006 Main Science and Technology Indicators 2008/1 OECD World Economic Outlook Database IMF GDP 3-11 3-11 GDP 2007 EU27 2006 Main Science and Technology Indicators 2008/1 OECD World Economic Outlook Database IMF 020406080100120140160 10 43 3-12 3-12 2006 Main Science and Technology Indicators 2008/1 OECD 44 3-13 3-13 1 THOMSON ESSENTIAL SCIENCE INDICATOR 2 THOMSON NATIO NAL SCIENCE INDICATOR 3 IMF WORLD ECONOMIC OUTLOOK DATABASE 2008 4 OECD MAIN SCIENCE AND TECHNOLOGY INDICATORS 2008 45 1998 2002 2003 2007 3-14 3-14 16 Thomson Essential Science Indicators

2 3-15 1998 2002 2003 2007 0%20%40%60%80%100%2003-2007 1998-2002 + + 3-15 47 Thomson Essential Science Indicators GDP 3-16 8 25% 3-17 10% 48 3-16 1 IMF WORLD ECONOMIC OUTLOOK DATABASE 2008 2 OECD MAIN SCIENCE AND TECHNOLOGY INDICATORS 2008 3-17 8 2006 9 2007 8 19 8 0%5%10%15%20%25%30% 49 6

3 4-1 1000 159 BIOTECHNOLOGY (47 ) FOOD & DRUG RETAILERS (4 ) HEALTH CARE EQUIPMENT & SERVICES (36 ) PHARMACEUTICALS (72 ) European Commission The 2008 EU Industrial R&D Investment Scoreboard 4-2 50 15 50 9 4-3 5 European Commission The 2008 EU Industrial R&D Investment Scoreboard 4-1 50 51 13 19 25 4-4 Medical Device Industry

4 Report 2007 , Espicom Business Intelligence 4-5 17 020406080100120140160180 GESiemensPhilips 52 4-6 10 X CT 3 5% 5 5 53 4-7 18 19 20 8

5 1 3 3 18 1998-2002 2003-2007 54 4-2 Nature Medicine Cell J Exp Med New Engl J Med Lancet JAMA 2003-2007 5 Article 2005 2006 200 2007 1 29 10 55 4-8 2007 2005 2006 2008 19 2

6 0500100015002000250030003500 56 4-9 1993-2001 4-10 4-11 : FDA 2008 4,239 426 FDA CDER(2,289 ), CBER(827 ),CDRH(1,123 ) 2007 PMDA 2008 57 10 2 2 4-12 IMS Health, IMS World Review 1998 2007 185,000 40 2,000 (NUS)

7 15 20 150 IT 18 1 63 58 R&D R&D VC 19 8 100 100 59 13 3,274 31% 4 1,170 30 4-13 9 4-14 NPO/ 16 -20 60 10 4-15 18 19 20 8 19 2

8 4-16 19 8 0%10%20%30%40%50%60%70%80%90%100%1996199 719981999200020012002200320042005 0%10%20%30%40%50%60%70% LSTP 5 5 61 4-17 2000 =100 4-18 62

9 63 4-19 1/2 1/8 4-20 IT EU industrial R&D investment scoreboard 64 10


Related search queries